Status | Study |
Not yet recruiting |
Study Name: EPO-4-Rhesus: Role of Darbepoetin Alfa in Reducing Late Anaemia in Neonates With Red Blood Cell Alloimmunization After Intrauterine Transfusions Condition: Erythroblastosis, Fetal Erythroblastosis Fetalis, Rh Disease Date: 2017-04-03 Interventions: Drug: Darbepoetin Alfa Darbepoetin alfa dosage 10microg/kg once a week for 8 weeks |
Not yet recruiting |
Study Name: In Utero Hematopoietic Stem Cell Transplantation for Alpha-thalassemia Major (ATM) Condition: Alpha Thalassemia Major Hemoglobinopathy; With Thalassemia Date: 2016-12-05 Interventions: Biological: in utero hematopoietic stem cell transplantation This is a phase 1 safety study to demonstra |
Not yet recruiting |
Study Name: Precision Medical Research of Non-immune Fetal Hydrops (NIFH)-From Prenatal Diagnosis to Intrauterine Treatment Condition: Fetal Hydrops Date: 2016-11-02 Interventions: Procedure: intrauterine intervention choose different surgeries according to different causes |
Terminated |
Study Name: Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR Condition: Hydrops Fetalis Fetal Growth Retardation Date: 2005-08-31 Interventions: Procedure: Tandem MS test for inborn errors of metabolism Tandem MS spectrometry test will be done on al |